Overall, in comparison with CD4-based CAR-T cell designs, monoclonal antibody-based CAR demonstrated a higher neutralizing capacity for different HIV-1 strains and showed an ability to avoid HIV infection (Figure 1Ai). Here, CD4 is linked to HIV infectious disease.